Please assess the completion status of the following clinical trial:

Trial Title: Néevo®/NéevoDHA® P.L.U.S. Program (Progress Through Learning, Understand & Support)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* New Néevo®/NéevoDHA® Start.~* Only for women who are pregnant and taking brand name Néevo®/ NéevoDHA® under a physicians care.~Exclusion Criteria:~* Patients who are not pregnant.~* If participant indicates that she did not get a prescription for Néevo®/ NéevoDHA®, she will not be able to complete the survey(s).~* For the follow-up survey, if the participant indicates that she has not been taking Néevo®/NéevoDHA®, she will not be able to complete the survey( (s).

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 39 Years
- Healthy Volunteers: t

Study Arms:
- Néevo®/NéevoDHA® (Type: None): Subjects who have been prescribed Néevo/NéevoDHA® daily.

Based on this trial design, predict the completion outcome and termination type (if applicable).